PT  - JOURNAL ARTICLE
AU  - Brendan Mulcahy
AU  - Daniel L. Rolnik
AU  - Alexia Matheson
AU  - Yizhen Liu
AU  - Kirsten R. Palmer
AU  - Ben W. Mol
AU  - Atul Malhotra
TI  - Preterm outcomes following COVID-19 lockdowns, Melbourne, Australia
AID  - 10.1101/2021.09.29.21264295
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.29.21264295
4099  - http://medrxiv.org/content/early/2021/10/02/2021.09.29.21264295.short
4100  - http://medrxiv.org/content/early/2021/10/02/2021.09.29.21264295.full
AB  - Background Community lockdowns during the coronavirus disease 2019 (COVID-19) pandemic may influence preterm birth rates, but mechanisms are unclear.Methods We compared neonatal outcomes of preterm infants born to mothers exposed to community lockdowns in 2020 (exposed group) to those born in 2019 (control group). Main outcome studied was composite of significant neonatal morbidity or death.Results Median gestational age was 35+4 weeks (295 infants, exposed group) vs. 35+0 weeks (347 infants, control group) (p = 0.108). The main outcome occurred in 36/295 (12.2%) infants in exposed group vs. 46/347 (13.3%) in control group (p = 0.69). Continuous positive airway pressure (CPAP) use, jaundice requiring phototherapy, hypoglycaemia requiring treatment, early neonatal white cell and neutrophil counts were significantly reduced in the exposed group.Conclusions COVID-19 community lockdowns did not alter composite neonatal outcomes in preterm infants, but reduced rates of some common outcomes as well as early neonatal inflammatory markers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNilAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from Monash Health Human Research Ethics Committee (approval number QA/69113/MonH-2020-235157).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available on reasonable request.